8 authorised products containing Omalizumab, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Omlyclo 150 mg solution for injection in pre-filled syringe EU/1/24/1817/002-004 |
Omalizumab | Celltrion Healthcare Hungary Kft. | — |
| Omlyclo 75 mg solution for injection in pre-filled syringe EU/1/24/1817/001 |
Omalizumab | Celltrion Healthcare Hungary Kft. | — |
| Xolair 150 mg powder and solvent for solution for injection EU/1/05/319/002 |
Omalizumab | Novartis Europharm Limited | — |
| Xolair 150 mg solution for injection in pre-filled syringe EU/1/05/319/8-10 |
Omalizumab | Novartis Europharm Limited | — |
| Xolair 300 mg solution for injection in pre-filled pen EU/1/05/319/015-017 |
Omalizumab | Novartis Europharm Limited | — |
| Xolair 300 mg solution for injection in pre-filled syringe EU/1/05/319/012-014 |
Omalizumab | Novartis Europharm Limited | — |
| Xolair 75 mg powder and solvent for solution for injection EU/1/05/319/001 |
Omalizumab | Novartis Europharm Limited | — |
| Xolair 75 mg solution for injection in pre-filled syringe EU/1/05/319/5-7 |
Omalizumab | Novartis Europharm Limited | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 7 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.